Summary and Future

The uncontrolled inhalational use of technical-grade NO is occurring for a variety of indications. Further complicating this situation is the scarcity of properly manufactured and inspected delivery and monitoring devices for inhaled NO therapy. Many clinicians use home assemblies of such equipment. 

Some researchers have tried to address this issue by participating in regional or national working parties or consensus groups, issuing recommendations for the use of inhaled NO in this preregistration phase. 

This work was supported in part by grant 9073 from the Swedish Medical Research Council and by grant HL-42397 from the U.S. National Heart, Lung and Blood Institute. C.G.F. and W.M.Z. are part-time consultants to industry on the development of therapeutic inhaled NO. The Massachusetts General Hospital has obtained a patent on the respiratory uses of nitric oxide. 

Adatia, I., Thompson, J., Landzberg, M., and Wessel, D. L. (1993). Inhaled nitric oxide in chronic obstructive lung disease. Lancet 341, 307-308. 

Kouyoumdjian, C., Defouiiloy, C., Andrivet, P., Sediame, S., Herigault, R., and Fratacci, M.-D. (1993). Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am. Rev. Respir. Dis. 148, 310-316. 

---

IV. EMERGING PICTURE OF FOOD SYSTEM MOBILITY SUMMARY AND FUTURE DIRECTIONS... 

Carver LA, Schnitzer JE, Anderson RG, Mohla S. Role of caveolae and lipid rafts in cancer workshop summary and future needs. Cancer Res 2003 63(20) 6571-6574. 

---